Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
   Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   A. Laakso et al., "Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia", SCHIZOPHR R, 52(1-2), 2001, pp. 115-120
2. Schmitt, A; Weber-Fahr, W; Jatzko, A; Tost, H; Henn, FA; Braus, DF
   Structural magnetic resonance imaging in schizophrenia: An overview
   FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
   
   A. Schmitt et al., "Structural magnetic resonance imaging in schizophrenia: An overview", F NEUR PSYC, 69(3), 2001, pp. 105-115
3. Konradi, C; Heckers, S
   Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia
   BIOLOGICAL PSYCHIATRY
   
   C. Konradi e S. Heckers, "Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia", BIOL PSYCHI, 50(10), 2001, pp. 729-742
4. Lieberman, J; Chakos, M; Wu, HW; Alvir, J; Hoffman, E; Robinson, D; Bilder, R
   Longitudinal study of brain morphology in first episode schizophrenia
   BIOLOGICAL PSYCHIATRY
   
   J. Lieberman et al., "Longitudinal study of brain morphology in first episode schizophrenia", BIOL PSYCHI, 49(6), 2001, pp. 487-499
5. Lawrie, SM; Whalley, HC; Abukmeil, SS; Kestelman, JN; Donnelly, L; Miller, P; Best, JJK; Owens, DGC; Johnstone, EC
   Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia
   BIOLOGICAL PSYCHIATRY
   
   S.M. Lawrie et al., "Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia", BIOL PSYCHI, 49(10), 2001, pp. 811-823
6. Lang, DJ; Kopala, LC; Vandorpe, RA; Rui, Q; Smith, GN; Goghari, VM; Honer, WG
   An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone
   AMERICAN JOURNAL OF PSYCHIATRY
   
   D.J. Lang et al., "An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone", AM J PSYCHI, 158(4), 2001, pp. 625-631
7. Altshuler, LL; Bartzokis, G; Grieder, T; Curran, J; Jimenez, T; Leight, K; Wilkins, J; Gerner, R; Mintz, J
   An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia
   BIOLOGICAL PSYCHIATRY
   
   L.L. Altshuler et al., "An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia", BIOL PSYCHI, 48(2), 2000, pp. 147-162
8. Remington, G; Chong, SA
   Conventional versus novel antipsychotics: changing concepts and clinical implications
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   G. Remington e S.A. Chong, "Conventional versus novel antipsychotics: changing concepts and clinical implications", J PSYCH NEU, 24(5), 1999, pp. 431-441
9. Harrison, PJ
   The neuropathological effects of antipsychotic drugs
   SCHIZOPHRENIA RESEARCH
   
   P.J. Harrison, "The neuropathological effects of antipsychotic drugs", SCHIZOPHR R, 40(2), 1999, pp. 87-99
10. Lee, H; Tarazi, FI; Chakos, M; Wu, HW; Redmond, M; Alvir, JM; Kinon, BJ; Bilder, R; Creese, I; Lieberman, JA
    Effects of chronic treatment with typical and atypical antipsychotic drugson the rat striatum
    LIFE SCIENCES
    
    H. Lee et al., "Effects of chronic treatment with typical and atypical antipsychotic drugson the rat striatum", LIFE SCI, 64(18), 1999, pp. 1595-1602
11. Corson, PW; Nopoulos, P; Miller, DD; Arndt, S; Andreasen, NC
    Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
    AMERICAN JOURNAL OF PSYCHIATRY
    
    P.W. Corson et al., "Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics", AM J PSYCHI, 156(8), 1999, pp. 1200-1204
12. WHITWORTH AB; HONEDER M; KREMSER C; KEMMLER G; FELBER S; HAUSMANN A; WANKO C; WECHDORN H; AICHNER F; STUPPAECK C; FLEISCHHACKER WW
    HIPPOCAMPAL VOLUME REDUCTION IN MALE-SCHIZOPHRENIC PATIENTS
    Schizophrenia research
    
    A.B. Whitworth et al., "HIPPOCAMPAL VOLUME REDUCTION IN MALE-SCHIZOPHRENIC PATIENTS", Schizophrenia research, 31(2-3), 1998, pp. 73-81
13. LIEBERMAN JA; SHEITMAN B; CHAKOS M; ROBINSON D; SCHOOLER N; KEITH S
    THE DEVELOPMENT OF TREATMENT RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA - A CLINICAL AND PATHOPHYSIOLOGIC PERSPECTIVE
    Journal of clinical psychopharmacology
    
    J.A. Lieberman et al., "THE DEVELOPMENT OF TREATMENT RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA - A CLINICAL AND PATHOPHYSIOLOGIC PERSPECTIVE", Journal of clinical psychopharmacology, 18(2), 1998, pp. 20-24
14. FRYE MA; KETTER TA; ALTSHULER LL; DENICOFF K; DUNN RT; KIMBRELL TA; CORALOCATELLI G; POST RM
    CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS
    Journal of affective disorders
    
    M.A. Frye et al., "CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS", Journal of affective disorders, 48(2-3), 1998, pp. 91-104
15. JESTE DV; LOHR JB; EASTHAM JH; ROCKWELL E; CALIGIURI MP
    ADVERSE NEUROBIOLOGICAL EFFECTS OF LONG-TERM USE OF NEUROLEPTICS - HUMAN AND ANIMAL STUDIES
    Journal of Psychiatric Research
    
    D.V. Jeste et al., "ADVERSE NEUROBIOLOGICAL EFFECTS OF LONG-TERM USE OF NEUROLEPTICS - HUMAN AND ANIMAL STUDIES", Journal of Psychiatric Research, 32(3-4), 1998, pp. 201-214
16. DEQUARDO JR; TANDON R
    DO ATYPICAL ANTIPSYCHOTIC MEDICATIONS FAVORABLY ALTER THE LONG-TERM COURSE OF SCHIZOPHRENIA
    Journal of Psychiatric Research
    
    J.R. Dequardo e R. Tandon, "DO ATYPICAL ANTIPSYCHOTIC MEDICATIONS FAVORABLY ALTER THE LONG-TERM COURSE OF SCHIZOPHRENIA", Journal of Psychiatric Research, 32(3-4), 1998, pp. 229-242
17. KESHAVAN MS; SCHOOLER NR; SWEENEY JA; HAAS GL; PETTEGREW JW
    RESEARCH AND TREATMENT STRATEGIES IN FIRST-EPISODE PSYCHOSES - THE PITTSBURGH EXPERIENCE
    British Journal of Psychiatry
    
    M.S. Keshavan et al., "RESEARCH AND TREATMENT STRATEGIES IN FIRST-EPISODE PSYCHOSES - THE PITTSBURGH EXPERIENCE", British Journal of Psychiatry, 172, 1998, pp. 60-65
18. CHAKOS MH; SHIRAKAWA O; LIEBERMAN J; LEE H; BILDER R; TAMMINGA CA
    STRIATAL ENLARGEMENT IN RATS CHRONICALLY TREATED WITH NEUROLEPTIC
    Biological psychiatry
    
    M.H. Chakos et al., "STRIATAL ENLARGEMENT IN RATS CHRONICALLY TREATED WITH NEUROLEPTIC", Biological psychiatry, 44(8), 1998, pp. 675-684
19. Gur, RE; Maany, V; Mozley, D; Swanson, C; Bilker, W; Gur, RC
    Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia
    AMERICAN JOURNAL OF PSYCHIATRY
    
    R.E. Gur et al., "Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia", AM J PSYCHI, 155(12), 1998, pp. 1711-1717
20. GILMORE JH; SIKICH L; LIEBERMAN JA
    NEUROIMAGING, NEURODEVELOPMENT, AND SCHIZOPHRENIA
    Child and adolescent psychiatric clinics of North America
    
    J.H. Gilmore et al., "NEUROIMAGING, NEURODEVELOPMENT, AND SCHIZOPHRENIA", Child and adolescent psychiatric clinics of North America, 6(2), 1997, pp. 325
21. HECKERS S
    NEUROPATHOLOGY OF SCHIZOPHRENIA - CORTEX, THALAMUS, BASAL GANGLIA, AND NEUROTRANSMITTER-SPECIFIC PROJECTION SYSTEMS
    Schizophrenia bulletin
    
    S. Heckers, "NEUROPATHOLOGY OF SCHIZOPHRENIA - CORTEX, THALAMUS, BASAL GANGLIA, AND NEUROTRANSMITTER-SPECIFIC PROJECTION SYSTEMS", Schizophrenia bulletin, 23(3), 1997, pp. 403-421
22. BUSATTO GF; KERWIN RW
    SCHIZOPHRENIA, PSYCHOSIS, AND THE BASAL GANGLIA
    The Psychiatric clinics of North America
    
    G.F. Busatto e R.W. Kerwin, "SCHIZOPHRENIA, PSYCHOSIS, AND THE BASAL GANGLIA", The Psychiatric clinics of North America, 20(4), 1997, pp. 897
23. RAPOPORT JL; GIEDD J; KUMRA S; JACOBSEN L; SMITH A; LEE P; NELSON J; HAMBURGER S
    CHILDHOOD-ONSET SCHIZOPHRENIA - PROGRESSIVE VENTRICULAR CHANGE DURINGADOLESCENCE
    Archives of general psychiatry
    
    J.L. Rapoport et al., "CHILDHOOD-ONSET SCHIZOPHRENIA - PROGRESSIVE VENTRICULAR CHANGE DURINGADOLESCENCE", Archives of general psychiatry, 54(10), 1997, pp. 897-903
24. LIEBERMAN JA; KOREEN AR; CHAKOS M; SHEITMAN B; WOERNER M; ALVIR JMJ; BILDER R
    FACTORS INFLUENCING TREATMENT RESPONSE AND OUTCOME OF FIRST-EPISODE SCHIZOPHRENIA - IMPLICATIONS FOR UNDERSTANDING THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA
    The Journal of clinical psychiatry
    
    J.A. Lieberman et al., "FACTORS INFLUENCING TREATMENT RESPONSE AND OUTCOME OF FIRST-EPISODE SCHIZOPHRENIA - IMPLICATIONS FOR UNDERSTANDING THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA", The Journal of clinical psychiatry, 57, 1996, pp. 5-9